切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Substance P/NK1 Receptor - Cdc42 - CMV - Inward Rectifier Potassium (Kir) Channels

10 件产品

每页
清除全部
  1. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  2. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  3. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  4. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  5. Ganciclovir
    B2097 Ganciclovir
    中文名: 更昔洛韦
    Target: CMV
    Summary: 针对CMV感染的抗病毒药
      ≥25.51 mg/mL
      ≥25.6 mg/mL
  6. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  7. ZCL278
    A8300 ZCL278
     1 Citation
    Target: Cdc42
    Summary: Cdc42抑制剂
      ≥29.25 mg/mL
      insoluble in H2O
  8. Cidofovir
    A5790 Cidofovir
    中文名: 西多福韦
    Target: CMV
    Summary: 抗CMV药;病毒DNA合成抑制剂
      insoluble in DMSO
      ≥13.95 mg/mL
  9. Aprepitant
    A1684 Aprepitant
    中文名: 阿瑞匹坦
    Target: Substance P/NK1 Receptor
    Summary: P物质(SP)抑制剂
      ≥26.72 mg/mL
      insoluble in H2O
  10. Glimepiride
    A4033 Glimepiride
    中文名: 格列美脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 磺酰脲类化合物
      ≥21.45 mg/mL
      insoluble in H2O

10 件产品

每页